Mead Johnson Nutrition CO (MJN) : Matthews International Capital Management reduced its stake in Mead Johnson Nutrition CO by 0.22% during the most recent quarter end. The investment management company now holds a total of 181,068 shares of Mead Johnson Nutrition CO which is valued at $16,105,999 after selling 400 shares in Mead Johnson Nutrition CO , the firm said in a disclosure report filed with the SEC on Aug 11, 2016.Mead Johnson Nutrition CO makes up approximately 0.66% of Matthews International Capital Management’s portfolio.
Other Hedge Funds, Including , Canada Pension Plan Investment Board reduced its stake in MJN by selling 114,900 shares or 90.06% in the most recent quarter. The Hedge Fund company now holds 12,682 shares of MJN which is valued at $1,128,064. William Blair Investment Management added MJN to its portfolio by purchasing 1,565,585 company shares during the most recent quarter which is valued at $138,992,636. Mead Johnson Nutrition CO makes up approx 0.52% of William Blair Investment Management’s portfolio.Hirtle Callaghan Co reduced its stake in MJN by selling 335 shares or 29.57% in the most recent quarter. The Hedge Fund company now holds 798 shares of MJN which is valued at $70,455. Mead Johnson Nutrition CO makes up approx 0.01% of Hirtle Callaghan Co’s portfolio.Nippon Life Insurance Co reduced its stake in MJN by selling 122 shares or 0.77% in the most recent quarter. The Hedge Fund company now holds 15,676 shares of MJN which is valued at $1,384,034. Mead Johnson Nutrition CO makes up approx 0.03% of Nippon Life Insurance Co’s portfolio.Msi Financial Services Inc reduced its stake in MJN by selling 493 shares or 17.56% in the most recent quarter. The Hedge Fund company now holds 2,314 shares of MJN which is valued at $211,962. Mead Johnson Nutrition CO makes up approx 0.01% of Msi Financial Services Inc’s portfolio.
Mead Johnson Nutrition CO closed down -0.35 points or -0.41% at $84.85 with 13,40,553 shares getting traded on Tuesday. Post opening the session at $85.42, the shares hit an intraday low of $84.78 and an intraday high of $85.59 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, Mead Johnson Nutrition CO reported $0.88 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.78. The company had revenue of $941.50 million for the quarter, compared to analysts expectations of $963.64 million. The company’s revenue was down -8.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.76 EPS.
Many Wall Street Analysts have commented on Mead Johnson Nutrition CO. CLSA Upgraded Mead Johnson Nutrition CO on Aug 3, 2016 to ” Outperform”, Price Target of the shares are set at $96.Mead Johnson Nutrition CO was Downgraded by Societe Generale to ” Hold” on Jul 29, 2016. Mead Johnson Nutrition CO was Upgraded by JP Morgan to ” Overweight” on Jul 26, 2016.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas childrens milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.